Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
HIGH RISK
Score updated Aug 28, 2026

TNXP — Tonix Pharmaceuticals Holding Corp. Dilution Risk Tracker

Track TNXP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNXP — Get alerts when the score changes →

As of August 28, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Tonix Pharmaceuticals Holding Corp. has a market capitalization of $196.55M, 17.15M shares outstanding, 82 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 37% potential dilution
• Convertible risk score very high (85/100)
🔔 Track TNXP — Get forecast alerts →

Market Data

Market Cap$196.55M
Shares Outstanding17.15M
Float15.92M
Cash$192.81M
Debt$7.49M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 47.2% shares (2026Q1 vs prior)
82 institutional holders · 5.76M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.04M shares
#2 BlackRock, Inc. 968.2K shares
#3 CITADEL ADVISORS LLC 511.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.60M
Days to Cover7.2
% of Float22.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31
xbrl XBRL CONVERTIBLE 2013-12-31
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-03-18
4 INSIDER TRANSACTION 2026-02-26
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TNXP Dilution Snapshot

Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TNXP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNXP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TNXP
TNXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.